Paper9155696
A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
Thomas MD and 8 others. J Clin Pathol, 1997. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status. Papers, record 9155696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9155696
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibody Specificity | Major topic |
| Enzyme-Linked Immunosorbent Assay | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Blotting, Western | |
| Breast Neoplasms | |
| Female | |
| Humans | |
| Immunohistochemistry |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2428616 | Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. | Eur J Biochem | 1986 | https://conductscience.org/library/papers/2428616 | PubMed |
| 2 | 2531845 | Mutations in the p53 gene occur in diverse human tumour types. | Nature | 1989 | https://conductscience.org/library/papers/2531845 | PubMed |
| 3 | 1905840 | p53 mutations in human cancers. | Science | 1991 | https://conductscience.org/library/papers/1905840 | PubMed |
| 4 | 1679056 | Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1679056 | PubMed |
| 5 | 1376364 | Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. | J Mol Biol | 1992 | https://conductscience.org/library/papers/1376364 | PubMed |
| 6 | 8554979 | p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8554979 | PubMed |
| 7 | 8502476 | Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry. | Oncogene | 1993 | https://conductscience.org/library/papers/8502476 | PubMed |
| 8 | 7685617 | Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique. | Br J Cancer | 1993 | https://conductscience.org/library/papers/7685617 | PubMed |
| 9 | 8251647 | Prognostic significance of p53 gene alterations in node-negative breast cancer. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8251647 | PubMed |
| 10 | 7524772 | Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7524772 | PubMed |
| 11 | 7537340 | Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. | J Mol Biol | 1995 | https://conductscience.org/library/papers/7537340 | PubMed |
| 12 | 1614522 | Cancer. p53, guardian of the genome. | Nature | 1992 | https://conductscience.org/library/papers/1614522 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34361728 | Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based Derivatives. | Molecules | 2021 | https://conductscience.org/library/papers/34361728 | PubMed |
| 33790542 | Nα-1, 3-Benzenedicarbonyl-Bis-(Amino Acid) and Dipeptide Candidates: Synthesis, Cytotoxic, Antimicrobial and Molecular Docking Investigation. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/33790542 | PubMed |
| 33530345 | Comparison of Metal Nanoparticles (Au, Ag, Eu, Cd) Used for Immunoanalysis Using LA-ICP-MS Detection. | Molecules | 2021 | https://conductscience.org/library/papers/33530345 | PubMed |
| 31286782 | In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N1,N3-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide. | J Enzyme Inhib Med Chem | 2019 | https://conductscience.org/library/papers/31286782 | PubMed |
| 21976978 | SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor. | Int J Nanomedicine | 2011 | https://conductscience.org/library/papers/21976978 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9155696
GET https://conductscience.org/api/papers/v1/9155696/authors